This startup develops a portable device that measures saliva biomarkers to provide users with instant access to their cortisol data. This enables customers to monitor their stress levels and identify potential indicators of prolonged stress or depression.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for measuring cortisol levels, a key indicator of stress, often require laboratory analysis of blood samples, which can be time-consuming, invasive, and inconvenient for frequent monitoring. Traditional point-of-care devices may sacrifice accuracy for convenience, leading to unreliable results.
Solution
ReMinded offers a portable, non-invasive platform for real-time cortisol measurement through saliva samples, providing accurate stress insights without the need for lab infrastructure. The device utilizes electrochemical biosensors to achieve lab-level accuracy, comparable to LC-MS standards, within minutes. By integrating quantitative cortisol data into care protocols, ReMinded aims to simplify the early detection and prevention of stress-related conditions. The technology is designed for expansion to a broad panel of biomarkers, unlocking applications across mental health, hormone health, cardiovascular care, and addiction treatment.
Target Audience
The primary target audience includes clinics and institutions focused on behavioral health, as well as healthcare providers seeking remote health testing solutions for personalized, proactive treatment of stress-related conditions.
Features
- Portable, non-invasive device for rapid cortisol measurement using saliva
- Electrochemical biosensors for high sensitivity and selectivity
- Lab-level accuracy (97% correlation with LC-MS) without complex infrastructure
- Optimized for the natural variability of saliva samples, ensuring consistent measurements
- Expansion capabilities to measure biomarkers such as serotonin, estrogen, testosterone, CRP, dopamine, cardiac troponin, and glucose